acute coronary syndrome
Conditions
Interventions
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai , China
Eligibility
Sex/Gender
All
Age
18 Years to 89 Years
Inclusion criteria
Inclusion criteria: 1. Case selection Acute Coronary Syndrome (ACS) Western medicine diagnostic criteria refer to the Guidelines for Non-ST Elevation Acute Coronary Syndrome issued by the European Society of Cardiology in 2015 and the Acute ST Guidelines for the diagnosis and treatment of segmental elevation myocardial infarction. The diagnostic criteria of TCM syndromes refer to the guidelines for clinical research of Zhongxiongbi in the "Guiding Principles for Clinical Research on New Chinese Medicines" and the revision of the hot-tox blood in the classification and revision of the "Eleventh Five-Year" key specialties of the State Administration of Traditional Chinese Medicine. Stasis syndrome, the main symptoms are: chest tightness such as suffocation and pain, or pain in the shoulders and back, upset, thick yellow sputum, dry stool, dark red or purple tongue, or petechiae, yellow greasy or slippery fur, slippery pulse or astringent; 2. Those who are 18-89 years old with coronary angiography showing vascular stenosis >=70% and stent implantation; 3. The patient and family members signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who have had ACS patients who have recurred ACS after PCI; 2. Non-atherosclerosis causes vascular stenosis and leads to ACS patients; 3. Concomitant with chronic inflammatory diseases such as chronic bronchitis, rheumatic valvular disease, connective tissue disease, etc. or use inflammation-suppressing drugs such as anti-inflammatory analgesics, steroids and immunosuppressive agents; 4. Patients with severe liver, kidney, hematopoietic and other important system diseases, or severe diseases that affect their survival (such as malignant tumors, etc.) and mental illness; 5. Patients with allergies, or allergies to various drugs and foods, or patients who are known to be allergic to the research drug (including its ingredients); 6.Participated in other drug trials within 1 months; 7. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| UCG+epicardial adipose tissue; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory factors;adiponectin;TCM symptom score scale; | — |
Countries
China
Contacts
Public ContactZhang Chunling
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed